Top Markets
#1 Islamic Coin Islamic Coin +154.31%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +31.84%
#4 RedStone RedStone +17.28%
#5 edgeX edgeX +16.67%
#6 Starpower Starpower +15.48%
#7 Meteora Meteora +13.37%
#8 Bio Protocol Bio Protocol +12.37%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.27%
#10 Lighter Lighter +12.26%
Coin of the day
Islamic Coin Islamic Coin
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
Peringkat dalam Saham #27805
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
Harga Saham
$0.0492516
Kapitalisasi Pasar
$30.41M
Perubahan (1 hari)
1.32%
Perubahan (1 tahun)
-91.28%
Negara
CN
Perdagangan Immunotech Biopharm Ltd (6978)

Kategori

Healthcare
Pendapatan untuk Immunotech Biopharm Ltd (6978)
Pendapatan pada Aug 2026 TTM: 0
Menurut laporan keuangan terbaru dari Immunotech Biopharm Ltd, pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Immunotech Biopharm Ltd dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH